Well, I think, first of all, we've been walking the talk, right? So we didn't do any shareholder remuneration until we get to 2.5. We're not yet there, we're almost there. So we're very confident for year-end. But I want to see it there before really opening that discussion. We'll get -- we have a strategic session with the board in the beginning of the year. Business wise, this is typically discussed. But we do have a lot of equity free cash flow coming in next year, like this year, plus the proceeds potentially from the towers. Let's wait until we have it in the bank and then make a decision. But, on the other side, we have Colombia M&A to pay for, but surely, if everything materializes, we will still have a significant amount of excess cash. Up to now, we've been repaying debt. We did more than $0.5 billion this year already. And so we could continue that. But it comes in a broader discussion of capital allocation. What do we do? Organic investment is the priority. But as Marcelo mentioned, the CapEx portfolio that we have today, we feel comfortable that is sufficient recurring and services and needs for the business. Then we have a continuous deleveraging and save on interest payments, which is good and have a strong balance sheet. We could do more M&A, nothing that is planned right now, but that's part of capital allocation decisions. And then lastly, and it's in no particular order, but then lastly, shareholder remuneration, either in the form of share buyback or in the form of dividends and then just the dividend policy, we would need to publish. If you do that, we would follow either an AGM in May or an EGM should be out of the cycle. So that's a bit the options on there. It's more giving you the menu than giving you a direction on where we are. But if everything works out, we should have excess cash during the year.